Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
about
The Concise Guide to PHARMACOLOGY 2013/14: enzymes.SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases.Development of fed-batch profiles for efficient biosynthesis of catechol-O-methyltransferase.Inhibition of human catechol-O-methyltransferase-mediated dopamine O-methylation by daphnetin and its Phase II metabolites.Inhibitory Effect of Bovine Lactoferrin on Catechol-O-Methyltransferase.An Optimized Two-Photon Fluorescent Probe for Biological Sensing and Imaging of Catechol-O-Methyltransferase.
P2860
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
@en
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders.
@nl
type
label
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
@en
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders.
@nl
prefLabel
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
@en
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders.
@nl
P2093
P2860
P356
P1476
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
@en
P2093
Baojian Wu
Hongming Liu
P2860
P304
P356
10.1111/BCP.12169
P407
P577
2014-03-01T00:00:00Z